標(biāo)題: Titlebook: Comprehensive Clinical Approach to Diabetes During Pregnancy; Dimitrios G. Goulis Book 2022 The Editor(s) (if applicable) and The Author(s [打印本頁(yè)] 作者: 凝固 時(shí)間: 2025-3-21 16:25
書目名稱Comprehensive Clinical Approach to Diabetes During Pregnancy影響因子(影響力)
書目名稱Comprehensive Clinical Approach to Diabetes During Pregnancy影響因子(影響力)學(xué)科排名
書目名稱Comprehensive Clinical Approach to Diabetes During Pregnancy網(wǎng)絡(luò)公開度
書目名稱Comprehensive Clinical Approach to Diabetes During Pregnancy網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Comprehensive Clinical Approach to Diabetes During Pregnancy被引頻次
書目名稱Comprehensive Clinical Approach to Diabetes During Pregnancy被引頻次學(xué)科排名
書目名稱Comprehensive Clinical Approach to Diabetes During Pregnancy年度引用
書目名稱Comprehensive Clinical Approach to Diabetes During Pregnancy年度引用學(xué)科排名
書目名稱Comprehensive Clinical Approach to Diabetes During Pregnancy讀者反饋
書目名稱Comprehensive Clinical Approach to Diabetes During Pregnancy讀者反饋學(xué)科排名
作者: 沙文主義 時(shí)間: 2025-3-21 21:15 作者: 束以馬具 時(shí)間: 2025-3-22 04:05 作者: 令人不快 時(shí)間: 2025-3-22 04:50
Epidemiologyropriate and timely diagnosis and management. This chapter will discuss the epidemiology of diabetes in pregnancy, building on previous research findings and focusing on trends in disease prevalence over time and how these differ by geographic area.作者: 的闡明 時(shí)間: 2025-3-22 12:42
Fetal Origin of Adult Disease: The Case of GDMnetic mechanisms affecting gene methylation, hormonal alterations, and hypothalamic changes. Identifying such mechanisms will allow targeted intervention in pregnancy and childhood to prevent the development of long-term adult disease.作者: 摘要 時(shí)間: 2025-3-22 16:22
Mohamed Al-Rubeai,Mariam Naciriropriate and timely diagnosis and management. This chapter will discuss the epidemiology of diabetes in pregnancy, building on previous research findings and focusing on trends in disease prevalence over time and how these differ by geographic area.作者: 摘要 時(shí)間: 2025-3-22 18:04 作者: 脖子 時(shí)間: 2025-3-22 22:58 作者: PRISE 時(shí)間: 2025-3-23 02:22 作者: bypass 時(shí)間: 2025-3-23 07:40 作者: aerial 時(shí)間: 2025-3-23 10:36
Vahid Serpooshan,Pilar Ruiz-Lozanoora of dietary supplements tested in randomized controlled trials in women with GDM, very few have demonstrated beneficial effects in maternal-fetal outcomes. An energy-prudent and nutritionally adequate diet comprises the core of all successful nutrition interventions.作者: 跟隨 時(shí)間: 2025-3-23 16:13 作者: Rinne-Test 時(shí)間: 2025-3-23 21:54
Targets and Rationale for Treatmenttional organizations and are based on consensus recommendations. This chapter presents glycemic target recommendations from different international organizations, normative glucose data in nondiabetic pregnancy and reviews research studies that have shaped the current guidelines for diabetes management in pregnancy.作者: 象形文字 時(shí)間: 2025-3-23 23:16 作者: 樣式 時(shí)間: 2025-3-24 06:26 作者: 旋轉(zhuǎn)一周 時(shí)間: 2025-3-24 07:58 作者: CORD 時(shí)間: 2025-3-24 10:41 作者: 影響深遠(yuǎn) 時(shí)間: 2025-3-24 17:32
978-3-030-89245-6The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: incite 時(shí)間: 2025-3-24 19:22
https://doi.org/10.1007/978-3-319-25427-2 adverse outcomes. It can manifest either as pre-existing or as DM initially diagnosed during pregnancy (gestational DM, GDM). This classification is crucial, since these two entities differ in terms of their impact on maternal and neonatal health, with GDM being the most prevalent (85% of cases). C作者: 滑動(dòng) 時(shí)間: 2025-3-25 00:29
Mohamed Al-Rubeai,Mariam Naciriestimated that over 20 million live births (around 1 in 6 pregnancies) were affected, and most of these cases were reported in low- and middle-income countries. Women with any form of hyperglycemia in pregnancy are at higher risk of adverse pregnancy outcomes, a fact that highlights the need for app作者: Ledger 時(shí)間: 2025-3-25 03:47
Gema Martin-Manso,Patrick J. Hanleynt are key to prevention of these complications. Most international guidelines have adopted the IADPSG 2010/WHO 2013 diagnostic criteria, for the diagnosis of GDM by recommending the following glycemic thresholds for a 75 g OGTT: fasting plasma glucose value ≥5.1 mmol/l (92 mg/dl); 1-h value ≥10.0 m作者: ARBOR 時(shí)間: 2025-3-25 09:14
Stem Cells and Good Manufacturing Practicese main risk factors for the development of GDM are increased maternal age, genetic factors, particular race/ethnicity, family history of diabetes, previous history of GDM, male fetus, multiple pregnancy, multiparous pregnancy, increased maternal body weight, maternal smoking, reduced physical activi作者: 沙發(fā) 時(shí)間: 2025-3-25 13:18 作者: Enrage 時(shí)間: 2025-3-25 16:48
Stem-Like Cells from Brain Tumours or ,?, and at birth, recent studies have linked GDM to risk for long-term disease in offspring, including impaired glucose tolerance and obesity. Investigations of the mechanisms by which GDM may “program” the exposed offspring to a higher risk of cardiometabolic disease later in life have suggested epige作者: Obvious 時(shí)間: 2025-3-25 21:16
Stem Cells and Lineage Commitmentted complications and improves pregnancy outcomes. A multidisciplinary therapeutic approach that includes lifestyle modification (nutrition therapy, exercise, body weight control) and pharmacological treatment, in cases that it is necessary, is recommended. The therapeutic goal of DM treatment durin作者: 字形刻痕 時(shí)間: 2025-3-26 01:01
Andrew S. Goldstein Ph.D.,Owen N. Witte M.D.es. In particular, an association of preexisting diabetes with increased congenital defects and stillbirth rates has been identified. In contrast, poor glycemic control, even in gestational diabetes mellitus, has been correlated with increased risk for macrosomia and shoulder dystocia during deliver作者: Forsake 時(shí)間: 2025-3-26 07:53 作者: Anticonvulsants 時(shí)間: 2025-3-26 11:51
https://doi.org/10.1007/978-1-4939-1435-7litus, including type 1 and type 2. The second part provides a thorough examination of potential strategies to reduce the risk of developing gestational diabetes.. The epidemiologic trends of diabetes mellitus among women of childbearing age cause an increase in the proportion of pregnancies affecte作者: 空洞 時(shí)間: 2025-3-26 13:51
Vahid Serpooshan,Pilar Ruiz-Lozanoto achieve normoglycemia, prevent ketosis, provide adequate gestational weight gain, and optimize fetal growth. Evidence-based MNT can negate pregnancy complications, improve obstetrical outcomes, and reduce the risk for maternal and fetal adverse events. Although achieving an energy equilibrium is 作者: 裝飾 時(shí)間: 2025-3-26 19:20 作者: Commonwealth 時(shí)間: 2025-3-26 21:20
Megan Summers,Karen Helm,Susan M. Majkahe mother and the fetus, as insulin does not cross the placenta. However, oral anti-hyperglycemic agents, including metformin and sulfonylureas, have been tried and are used in women with GDM in everyday practice worldwide, though the official Food and Drug Administration (FDA) license is still miss作者: 宴會(huì) 時(shí)間: 2025-3-27 03:26 作者: 我沒有強(qiáng)迫 時(shí)間: 2025-3-27 07:51 作者: collagen 時(shí)間: 2025-3-27 11:25 作者: 服從 時(shí)間: 2025-3-27 14:36 作者: 的染料 時(shí)間: 2025-3-27 19:29 作者: 加強(qiáng)防衛(wèi) 時(shí)間: 2025-3-27 23:15
Epidemiologyestimated that over 20 million live births (around 1 in 6 pregnancies) were affected, and most of these cases were reported in low- and middle-income countries. Women with any form of hyperglycemia in pregnancy are at higher risk of adverse pregnancy outcomes, a fact that highlights the need for app作者: 爭(zhēng)論 時(shí)間: 2025-3-28 02:18
Diagnosis of Gestational Diabetes Mellitusnt are key to prevention of these complications. Most international guidelines have adopted the IADPSG 2010/WHO 2013 diagnostic criteria, for the diagnosis of GDM by recommending the following glycemic thresholds for a 75 g OGTT: fasting plasma glucose value ≥5.1 mmol/l (92 mg/dl); 1-h value ≥10.0 m作者: Campaign 時(shí)間: 2025-3-28 09:48
Risk Factors for Developing Gestational Diabetes Mellituse main risk factors for the development of GDM are increased maternal age, genetic factors, particular race/ethnicity, family history of diabetes, previous history of GDM, male fetus, multiple pregnancy, multiparous pregnancy, increased maternal body weight, maternal smoking, reduced physical activi作者: aesthetician 時(shí)間: 2025-3-28 13:01
Pathophysiologymajority being women who develop gestational diabetes (GDM). This affects especially women with predisposing factors such as polycystic ovary syndrome or a family history of type 2 diabetes. The diagnosis of GDM has consequences for the newborn (e.g., macrosomia and its sequelae), the young child (e作者: 戰(zhàn)勝 時(shí)間: 2025-3-28 16:30
Fetal Origin of Adult Disease: The Case of GDM and at birth, recent studies have linked GDM to risk for long-term disease in offspring, including impaired glucose tolerance and obesity. Investigations of the mechanisms by which GDM may “program” the exposed offspring to a higher risk of cardiometabolic disease later in life have suggested epige作者: HPA533 時(shí)間: 2025-3-28 20:59
Medical Monitoring of Preexisting DM and GDMted complications and improves pregnancy outcomes. A multidisciplinary therapeutic approach that includes lifestyle modification (nutrition therapy, exercise, body weight control) and pharmacological treatment, in cases that it is necessary, is recommended. The therapeutic goal of DM treatment durin作者: defibrillator 時(shí)間: 2025-3-29 00:29
Obstetrical Monitoringes. In particular, an association of preexisting diabetes with increased congenital defects and stillbirth rates has been identified. In contrast, poor glycemic control, even in gestational diabetes mellitus, has been correlated with increased risk for macrosomia and shoulder dystocia during deliver作者: 流逝 時(shí)間: 2025-3-29 04:56 作者: 龍蝦 時(shí)間: 2025-3-29 09:44 作者: 解開 時(shí)間: 2025-3-29 13:05 作者: 山崩 時(shí)間: 2025-3-29 17:54 作者: 運(yùn)動(dòng)吧 時(shí)間: 2025-3-29 20:33
Oral Anti-Hyperglycemic Agentshe mother and the fetus, as insulin does not cross the placenta. However, oral anti-hyperglycemic agents, including metformin and sulfonylureas, have been tried and are used in women with GDM in everyday practice worldwide, though the official Food and Drug Administration (FDA) license is still miss作者: 撫慰 時(shí)間: 2025-3-30 00:06 作者: 致敬 時(shí)間: 2025-3-30 04:10 作者: BOON 時(shí)間: 2025-3-30 10:45
https://doi.org/10.1007/978-3-319-25427-2y and individual history of GDM. Maternal complications include increased risk of preterm birth, arterial hypertension, preeclampsia, cesarian delivery, and increased risk of T2DM and cardiovascular disease in later life. Short-term fetal risks include macrosomia, shoulder dystocia, birth trauma, hy作者: PALL 時(shí)間: 2025-3-30 14:31 作者: 愛了嗎 時(shí)間: 2025-3-30 16:54 作者: 拖債 時(shí)間: 2025-3-30 21:05 作者: Trypsin 時(shí)間: 2025-3-31 01:04
Andrew S. Goldstein Ph.D.,Owen N. Witte M.D.illance with a combination of cardiotocography, ultrasound, biophysical profile, and fetal movements assessment is recommended during the third trimester. Despite the great progress made in the management of diabetic pregnant women during the past decades, there is still limited evidence on the opti作者: 游行 時(shí)間: 2025-3-31 06:24 作者: EVADE 時(shí)間: 2025-3-31 10:13 作者: flimsy 時(shí)間: 2025-3-31 15:33
https://doi.org/10.1007/978-3-319-98065-2with continuous intrapartum fetal heart rate monitoring. Obstetric management should be accompanied by regular evaluation of maternal blood glucose levels to prevent adverse neonatal outcomes. During the puerperium, breastfeeding should be encouraged, and appropriate family planning and long-term sc作者: Oratory 時(shí)間: 2025-3-31 20:34
Comprehensive Clinical Approach to Diabetes During Pregnancy作者: 剝削 時(shí)間: 2025-3-31 21:47
